TF
BMY icon

Tudor Financial’s Bristol-Myers Squibb BMY Stock Holding History

Tudor Financial’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$322K Buy
5,306
+14
+0.3% +$816 0.16% 115
2025
Q4 		$285K Sell
5,292
-1,185
-18% -$57K 0.15% 126
2025
Q3 		$292K Sell
6,477
-22
-0.3% -$1.03K 0.16% 121
2025
Q2 		$301K Sell
6,499
-458
-7% -$22.5K 0.17% 118
2025
Q1 		$424K Buy
6,957
+396
+6% +$23.1K 0.25% 94
2024
Q4 		$371K Buy
6,561
+1,727
+36% +$96.5K 0.22% 105
2024
Q3 		$250K Buy
+4,834
New +$227K 0.15% 118

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tudor Financial's BMY Position: Q1 2026 in Review

Tudor Financial increased its Bristol-Myers Squibb (BMY) stake by 0.26% in Q1 2026, buying an estimated $816 and bringing the position to 5,306 shares worth $322K. The position accounts for 0.16% of the portfolio, ranked #115.

Tudor Financial first reported a position in BMY in Q3 2024 and has held it in 7 quarters since. The position peaked at $424K in Q1 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Tudor Financial held 5,306 shares of Bristol-Myers Squibb worth $322K as of Q1 2026.
  • Tudor Financial bought 14 Bristol-Myers Squibb shares in Q1 2026, an estimated $816.
  • Bristol-Myers Squibb made up 0.16% of Tudor Financial's portfolio in Q1 2026, its #115 holding.
  • Tudor Financial first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 7 quarters since.
  • Tudor Financial's Bristol-Myers Squibb position peaked at $424K in Q1 2025.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Tudor Financial's 13F filing for Q1 2026, filed 14 May 2026.